ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
122.799,09
-1,60%
S&P 500
5.954,50
1,59%
US Dollar vs BRL
5,886
0,00%
Bitcoin
85.424,86
1,25%
Brent Oil
73,045
0,00%
As Melhores Corretoras Online
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Lisata Therapeutics Inc (LSTA)

  7. Lisata Therapeutics Inc (LSTA) Notícias

LSTA

Lisata Therapeutics (LSTA)

Lisata Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:LSTA
DataHoraFonteTítuloCódigoCompanhia
27/02/202518:05GlobeNewswire Inc.Lisata Therapeutics Reports Full Year 2024 Financial Results and Provides Business UpdateNASDAQ:LSTALisata Therapeutics Inc
20/02/202510:00GlobeNewswire Inc.Lisata Therapeutics to Report Full Year 2024 Financial Results and Provide a Business Update on Thursday, February 27, 2025NASDAQ:LSTALisata Therapeutics Inc
05/02/202510:30GlobeNewswire Inc.Lisata Therapeutics to Present at the 2025 BIO CEO & Investor ConferenceNASDAQ:LSTALisata Therapeutics Inc
23/01/202510:00GlobeNewswire Inc.Lisata Therapeutics and WARPNINE Announce Encouraging Preliminary Results from the Phase 1b/2a iLSTA Trial Evaluating Certepetide in Locally Advanced Non-Resectable Pancreatic Ductal AdenocarcinomaNASDAQ:LSTALisata Therapeutics Inc
22/01/202510:00GlobeNewswire Inc.Lisata Therapeutics Reports Encouraging Preliminary Cohort A Data from the AGITG-led Phase 2 ASCEND Trial Evaluating Certepetide with Standard-of-Care Chemotherapy in Metastatic Pancreatic Ductal AdenocarcinomaNASDAQ:LSTALisata Therapeutics Inc
15/01/202510:30GlobeNewswire Inc.Lisata Therapeutics to Present at the 2025 Sequire Investor SummitNASDAQ:LSTALisata Therapeutics Inc
10/12/202410:30GlobeNewswire Inc.Lisata Therapeutics Announces Completion of Enrollment in the CENDIFOX TrialNASDAQ:LSTALisata Therapeutics Inc
03/12/202410:30GlobeNewswire Inc.Lisata Therapeutics and Kuva Labs Announce Global License Agreement for Solid Tumor ImagingNASDAQ:LSTALisata Therapeutics Inc
19/11/202410:30GlobeNewswire Inc.Lisata Therapeutics Wins 2024 BioTech Breakthrough Award for ‘Specialized BioTherapeutics Company of the Year’NASDAQ:LSTALisata Therapeutics Inc
12/11/202418:05GlobeNewswire Inc.Lisata Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:LSTALisata Therapeutics Inc
06/11/202411:23GlobeNewswire Inc.Lisata Therapeutics and Valo Therapeutics Announce Preclinical Research CollaborationNASDAQ:LSTALisata Therapeutics Inc
06/11/202410:30GlobeNewswire Inc.Lisata Therapeutics to Report Third Quarter 2024 Financial Results and Provide a Business Update on Tuesday, November 12, 2024NASDAQ:LSTALisata Therapeutics Inc
31/10/202409:30GlobeNewswire Inc.Lisata Therapeutics to Participate in Upcoming November 2024 Industry and Investor EventsNASDAQ:LSTALisata Therapeutics Inc
28/10/202409:30GlobeNewswire Inc.Lisata Therapeutics Announces Sponsored Preclinical Research Agreement with the University of Cincinnati to Study Certepetide for the Treatment of EndometriosisNASDAQ:LSTALisata Therapeutics Inc
03/10/202409:00GlobeNewswire Inc.Lisata Therapeutics to Participate in Upcoming October 2024 Industry and Investor EventsNASDAQ:LSTALisata Therapeutics Inc
17/09/202409:00GlobeNewswire Inc.Lisata Therapeutics Announces First Patient Treated in the Second-line Cholangiocarcinoma Cohort of the BOLSTER TrialNASDAQ:LSTALisata Therapeutics Inc
09/09/202409:00GlobeNewswire Inc.Lisata Therapeutics to Participate in Upcoming September 2024 Industry and Investor EventsNASDAQ:LSTALisata Therapeutics Inc
05/09/202409:00GlobeNewswire Inc.Lisata Therapeutics’ Certepetide Granted FDA Orphan Drug Designation for the Treatment of CholangiocarcinomaNASDAQ:LSTALisata Therapeutics Inc
12/08/202417:05GlobeNewswire Inc.Lisata Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:LSTALisata Therapeutics Inc
05/08/202409:00GlobeNewswire Inc.Lisata Therapeutics to Report Second Quarter 2024 Financial Results and Provide a Business Update on Monday, August 12, 2024NASDAQ:LSTALisata Therapeutics Inc
18/07/202409:00GlobeNewswire Inc.Haystack Oncology and Lisata Therapeutics Initiate Research Collaboration to Use the Haystack MRD™ Technology to Evaluate Efficacy of Pancreatic Cancer TherapyNASDAQ:LSTALisata Therapeutics Inc
16/07/202409:00GlobeNewswire Inc.Lisata Therapeutics Announces Completion of Enrollment in its Phase 2a BOLSTER Trial of Certepetide in First-Line CholangiocarcinomaNASDAQ:LSTALisata Therapeutics Inc
10/07/202409:00GlobeNewswire Inc.Lisata Therapeutics’ Certepetide Shows Promise in Improving Standard Treatment for Intrahepatic Cholangiocarcinoma in a Preclinical ModelNASDAQ:LSTALisata Therapeutics Inc
13/06/202409:30GlobeNewswire Inc.Lisata Therapeutics Announces Full Enrollment of Pancreatic Cancer Cohort of CENDIFOX TrialNASDAQ:LSTALisata Therapeutics Inc
28/05/202409:30GlobeNewswire Inc.Lisata Therapeutics to Participate in Upcoming June 2024 Industry and Investor EventsNASDAQ:LSTALisata Therapeutics Inc
20/05/202409:30GlobeNewswire Inc.Lisata Therapeutics Receives Paediatric Investigation Plan Waiver from the European Medicines Agency for Certepetide in Pancreatic CancerNASDAQ:LSTALisata Therapeutics Inc
10/05/202401:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LSTALisata Therapeutics Inc
09/05/202417:13Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LSTALisata Therapeutics Inc
09/05/202417:05GlobeNewswire Inc.Lisata Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:LSTALisata Therapeutics Inc
08/05/202409:00GlobeNewswire Inc.Lisata Therapeutics to Participate in Upcoming May 2024 Industry and Investor EventsNASDAQ:LSTALisata Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:LSTA

Seu Histórico Recente

BOV
P1EA34M
Healthpeak OP
LSE
MIVO
Amundi Eu Mivol
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados

Vá sem anúncios

Assine uma experiência sem anúncios

Sem anúncios

Experimente agora

Manter os anúncios